Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant | NEJM – nejm.org

.
1-800-843-6356|[email secured]

Our
apologies. A mistake took place while setting your user cookie. Please set your
browser to accept cookies to continue.
NEJM.org utilizes cookies to enhance performance by remembering your
session ID when you browse from page to page. This cookie shops just a.
session ID; no other details is captured. Accepting the NEJM cookie is.
needed to use the site